BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22595872)

  • 1. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
    Heffron R; Ngure K; Mugo N; Celum C; Kurth A; Curran K; Baeten JM
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):116-9. PubMed ID: 22595872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
    Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
    PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
    AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals and safer conception for HIV-serodiscordant couples.
    Matthews LT; Smit JA; Cu-Uvin S; Cohan D
    Curr Opin HIV AIDS; 2012 Nov; 7(6):569-78. PubMed ID: 23032734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.
    Irungu EM; Heffron R; Mugo N; Ngure K; Katabira E; Bulya N; Bukusi E; Odoyo J; Asiimwe S; Tindimwebwa E; Celum C; Baeten JM;
    BMC Infect Dis; 2016 Oct; 16(1):571. PubMed ID: 27751179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples.
    Ngure K; Kimemia G; Dew K; Njuguna N; Mugo N; Celum C; Baeten JM; Heffron R
    J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21309. PubMed ID: 28361508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan.
    Ko NY; Wu HJ; Strong C; Li CW; Ku WW; Hsu ST
    AIDS Care; 2018 Oct; 30(10):1306-1310. PubMed ID: 29845871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.
    Curran K; Ngure K; Shell-Duncan B; Vusha S; Mugo NR; Heffron R; Celum C; Baeten JM
    AIDS; 2014 Jan; 28(2):227-33. PubMed ID: 24413310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda.
    Ware NC; Pisarski EE; Nakku-Joloba E; Wyatt MA; Muwonge TR; Turyameeba B; Asiimwe SB; Heffron RA; Baeten JM; Celum CL; Katabira ET
    J Int AIDS Soc; 2018 May; 21(5):e25113. PubMed ID: 29851436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.
    Ying R; Sharma M; Heffron R; Celum CL; Baeten JM; Katabira E; Bulya N; Barnabas RV
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20013. PubMed ID: 26198348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.
    Murnane PM; Celum C; Mugo N; Campbell JD; Donnell D; Bukusi E; Mujugira A; Tappero J; Kahle EM; Thomas KK; Baeten JM;
    AIDS; 2013 Aug; 27(13):2155-60. PubMed ID: 24384592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
    Nakku-Joloba E; Pisarski EE; Wyatt MA; Muwonge TR; Asiimwe S; Celum CL; Baeten JM; Katabira ET; Ware NC
    J Int AIDS Soc; 2019 Jan; 22(1):e25225. PubMed ID: 30657642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.
    Heffron R; Ngure K; Velloza J; Kiptinness C; Quame-Amalgo J; Oluch L; Thuo N; Njoroge J; Momanyi R; Gakuo S; Mbugua S; Morrison S; Haugen H; Chohan B; Celum C; Baeten JM; Mugo N
    J Int AIDS Soc; 2019 Apr; 22(4):e25261. PubMed ID: 30957420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.